Internal Medicine, Interventional Cardiology · Alhambra, CA
NPI
1871519561
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
220 S 1st St
Alhambra, CA, 91801
Phone (626) 281-8663
Groups this clinician bills Medicare through
Medicare paid, 2024
$365K
4,323 services
Medicare patients, 2024
1,080
Average age 79
Drug cost, 2024
$1.7M
10,282 prescriptions
Company payments, 2025
$1,067
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter K Fung was code 99214 (office e&m - established), 1,379 times for 777 patients. In total Peter K Fung billed 4,323 services in 40 codes, and Medicare paid $365K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,379 | 777 | $101.29 | $140K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 672 | 168 | $6.00 | $4,034 |
| 99213 Office E&M - Established | Office | 642 | 486 | $69.35 | $45K |
| 93000 Electrocardiogram | Office | 533 | 483 | $11.49 | $6,124 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 356 | 178 | $184.14 | $66K |
| 93015 Electrocardiogram | Office | 177 | 177 | $54.57 | $9,659 |
| 78452 Myocardial Perfusion Scan | Office | 177 | 177 | $388.05 | $69K |
| 99204 Office E&M - New | Office | 134 | 134 | $131.29 | $18K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 127 | 127 | $0.52 | $66.2 |
| 99442 Telephone Services | Office | 14 | 14 | $46.93 | $657 |
| 76937 Ultrasound - Nonspecific | Facility | 12 | 12 | $11.13 | $134 |
| 99203 Office E&M - New | Office | 11 | 11 | $80.17 | $882 |
By year: 2022 $371K for 4,894 services; 2023 $306K for 3,998 services; 2024 $365K for 4,323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter K Fung prescribed most often to Medicare patients was Metoprolol Succinate, with 1,002 prescriptions and refills. In total Peter K Fung wrote 10,282 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,002 | 2,281 | 271 | $14K |
| Amlodipine Besylate Generic | 853 | 2,016 | 255 | $5,540 |
| Atorvastatin Calcium Generic | 852 | 2,093 | 264 | $8,023 |
| Losartan Potassium Generic | 654 | 1,563 | 201 | $6,820 |
| Eliquis Apixaban | 608 | 1,100 | 148 | $637K |
| Rosuvastatin Calcium Generic | 385 | 870 | 111 | $6,704 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 384 | 752 | 90 | $4,881 |
| Carvedilol Generic | 365 | 859 | 98 | $3,106 |
| Clopidogrel Clopidogrel Bisulfate | 331 | 788 | 99 | $3,376 |
| Furosemide Generic | 230 | 430 | 76 | $734 |
| Ranolazine Er Ranolazine | 222 | 386 | 54 | $20K |
| Hydrochlorothiazide Generic | 193 | 454 | 70 | $731 |
| Pravastatin Sodium Generic | 171 | 467 | 60 | $2,297 |
| Xarelto Rivaroxaban | 169 | 312 | 36 | $167K |
| Olmesartan Medoxomil Generic | 167 | 376 | 48 | $3,301 |
Brand drugs: 1,644 claims; generic drugs: 8,638 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter K Fung $1,067 ($1,067 in general payments such as food, travel and fees) from 10 companies. The largest payer was Merck Sharp & Dohme LLC with $320.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 11 | $320 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $184 |
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $162 |
| Pfizer Inc. PFE | 9 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $70.95 |
| Amgen Inc. AMGN | 2 | $48.39 |
| Kestra Medical Technology Services, Inc. | 2 | $39.1 |
| CVRx, Inc. CVRX | 1 | $32.31 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $30.54 |
| GlaxoSmithKline, LLC. GSK | 1 | $18.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.